FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

IMC-11F8 News

Most Popular IMC-11F8 Story

Did BMS bid to avoid ImClone dispute?

When Bristol-Myers Squibb announced its bid to buy its partner ImClone, a lot of people asked, Why now? ImClone's stock is a lot higher now than it was a couple of years ago. So if BMS didn't make an... Read more...

Latest Headlines